Guess what causes Myocarditis and what doesn’t?


Myocarditis after the BNT162b2 mRNA anti-COVID-19 vaccine has been reported in around 1 on 100,000, and is higher in males than in females with top incidence in young males, aged 16–19 years. The incidence of post-vaccination myocarditis appears mildly more pronounced following mRNA-1273 (Moderna) administration. Clinically, it manifests a few days after vaccine administration and is considered unlikely connectable to vaccination after 4 weeks.

Diagnosis is usually obtained through clinical considerations and non-invasive investigations, including ECG, echocardiogram, troponin I determination, and cardiac magnetic resonance imaging. Endomyocardial biopsy has been undertaken in a very limited number of cases and this limits the available knowledge on the pathway.

Interestingly, infection with SARS-CoV2 increases the risk of myocarditis by 16-fold from 9 per 100,000 to 150 cases per 100,000, and seems to be more severe.

On the other hand, myocarditis following COVID-19 vaccination is reported as benign in 95% of cases with spontaneous resolution and very occasional fulminant forms and death.”

“Willful blindness” to acknowledge ALL possible causes of excess deaths

US Authorities are guilty